Milestone Scientific (NYSE: MLSS) directors plan bridge note conversions
Rhea-AI Filing Summary
Milestone Scientific Inc. reports that three directors, Benedetta Casamento, Dr. Didier Demesmin and Neal Goldman, have delivered notices electing to convert the remaining principal and accrued interest on their Convertible Bridge Notes into common stock. These notes were originally issued as part of a series of promissory notes with aggregate principal of $800,000.
The outstanding principal subject to these elections is $116,495.47 for Ms. Casamento, $58,247.73 for Dr. Demesmin and $291,238.66 for Mr. Goldman. Conversions will occur automatically once the common stock’s Fair Value is at least $0.50 per share and each director is permitted to trade under the company’s Insider Trading Policy. No shares have been issued under these elections as of the report date.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Aggregate principal of promissory notes: $800,000
Outstanding principal for Benedetta Casamento: $116,495.47
Outstanding principal for Dr. Didier Demesmin: $58,247.73
+3 more
6 metrics
Aggregate principal of promissory notes
$800,000
Series of promissory notes originally issued to holders
Outstanding principal for Benedetta Casamento
$116,495.47
Principal amount on Convertible Bridge Note subject to conversion election
Outstanding principal for Dr. Didier Demesmin
$58,247.73
Principal amount on Convertible Bridge Note subject to conversion election
Outstanding principal for Neal Goldman
$291,238.66
Principal amount on Convertible Bridge Note subject to conversion election
Conversion trigger price
$0.50 per share
Minimum Fair Value of common stock required for automatic conversion
Par value of common stock
$0.001 per share
Par value of Milestone Scientific’s common stock into which notes convert
Key Terms
Convertible Bridge Notes, Fair Value, Insider Trading Policy, Notice of Conversion
4 terms
Convertible Bridge Notes financial
"the Company’s amended and restated promissory notes held by the Holders (the Convertible Bridge Notes)"
A convertible bridge note is a short-term loan a company takes to 'bridge' its funding until a larger financing round, with the loan automatically converting into shares instead of being repaid in cash. For investors, it matters because it behaves like an IOU that will become ownership at a future price (often at a reduced rate compared with new investors), affecting future share count, potential upside, and dilution risk.
Fair Value financial
"at such time as the Fair Value of the shares of Common Stock of the Company"
Fair value is an estimate of what an asset or company is really worth today, derived from expected future earnings, comparable market prices and other relevant facts—like agreeing a price for a used car after checking mileage, condition and similar listings. Investors use fair value to decide whether a stock looks overpriced or undervalued, which helps guide buy, hold or sell decisions and sets expectations for potential returns and risk.
Insider Trading Policy regulatory
"in compliance with the Insider Trading Policy of the Company, including without limitation obtaining any necessary pre-clearance"
A written set of rules that tells employees, executives and board members what information they may not use to buy or sell a company's stock and when trading is allowed. Think of it as a playbook or house rules that prevent people with secret knowledge from getting an unfair advantage; it matters to investors because it helps protect fair markets, preserves trust in management, and reduces the risk of legal penalties that can hurt a company’s value.
Notice of Conversion financial
"Form of Notice of Conversion of Promissory Note (pursuant to Section 5(a) of the Note)"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Milestone Scientific (MLSS) disclose about its Convertible Bridge Notes?
Milestone Scientific disclosed that three directors submitted elections to convert the remaining principal and accrued interest on their Convertible Bridge Notes into common stock. These conversions will occur automatically once pricing and trading-condition triggers in the notes and Insider Trading Policy are satisfied.
How much principal remains to be converted for each Milestone Scientific (MLSS) director?
The remaining principal covered by the conversion elections is $116,495.47 for Benedetta Casamento, $58,247.73 for Dr. Didier Demesmin and $291,238.66 for Neal Goldman. These amounts represent the outstanding principal on their respective Convertible Bridge Notes subject to conversion.
When will the Milestone Scientific (MLSS) Convertible Bridge Notes actually convert into stock?
The notes will convert automatically once the common stock’s Fair Value is not less than $0.50 per share and the applicable director is allowed to buy and sell company securities under Milestone Scientific’s Insider Trading Policy, including any required pre-clearance.
What are the key terms of Milestone Scientific’s (MLSS) Convertible Bridge Notes mentioned here?
The notes are amended and restated promissory notes originally issued as part of a $800,000 aggregate principal series. They were partially converted on April 20, 2026, and the remaining principal and interest can convert into common stock once the Fair Value reaches at least $0.50 per share.